Form 4: BioLife Solutions Officer Sells Shares for Tax Obligations
Insider Transaction Report
BioLife Solutions' Chief Quality and Operations, Karen A. Foster, sold 519 shares of common stock to cover tax withholding obligations.
Summary
- Karen A. Foster, Chief Quality and Operations of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
- On December 9, 2025, Foster sold 519 shares of BLFS common stock at a price of $25.13 per share.
- The total value of the shares sold is approximately $13,032.07.
- Following this transaction, Foster beneficially owns 192,319 shares of common stock.
- The sale was executed under a Rule 10b5-1(c) trading plan, adopted on March 8, 2024, specifically to satisfy tax withholding obligations related to the vesting of restricted stock.
Sentiment
Score: 5
Explanation: The transaction is a routine insider sale for tax purposes under a pre-arranged plan, indicating a neutral impact on company sentiment.
Future Outlook
NA
Industry Context
This is a routine insider transaction for tax purposes and does not reflect broader industry trends or competitive positioning. Such sales are common for executives receiving equity compensation.
Stakeholder Impact
- Minimal direct impact on shareholders as this is a small, routine sale by an executive for tax purposes, not indicative of a change in company fundamentals or executive confidence.
- No direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03-08-2024 | Date Rule 10b5-1(c) trading plan was adopted by Karen A. Foster. |
| 12/09/2025 | Date of transaction where Karen A. Foster sold common stock. |
| 12/17/2025 | Date the Form 4 was signed by Karen A. Foster. |
Recommendation
holdThis Form 4 filing reports a routine insider sale by an executive to cover tax obligations associated with restricted stock vesting, executed under a pre-arranged 10b5-1 plan. Such transactions are common and generally do not reflect a change in the executive's long-term outlook on the company or its fundamentals. Therefore, it provides no new information that would warrant a change in investment recommendation based solely on this filing.
Keywords
BioLife Solutions, BLFS, Form 4, Insider Trading, Stock Sale, Karen A. Foster, Rule 10b5-1, Tax Withholding, Restricted Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.